These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 29061424)

  • 1. Dopamine transporter gene polymorphism in children with ADHD: A pilot study in Indonesian samples.
    Wiguna T; Ismail RI; Winarsih NS; Kaligis F; Hapsari A; Budiyanti L; Sekartini R; Rahayu S; Guerrero APS
    Asian J Psychiatr; 2017 Oct; 29():35-38. PubMed ID: 29061424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the DAT1 polymorphism with attention deficit hyperactivity disorder (ADHD): a family-based approach.
    Lim MH; Kim HW; Paik KC; Cho SC; Yoon DY; Lee HJ
    Am J Med Genet B Neuropsychiatr Genet; 2006 Apr; 141B(3):309-11. PubMed ID: 16526026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dopamine transporter gene and the impulsivity phenotype in attention deficit hyperactivity disorder: a case-control association study in a Korean sample.
    Kim JW; Kim BN; Cho SC
    J Psychiatr Res; 2006 Dec; 40(8):730-7. PubMed ID: 16368111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine transporter gene moderates response to behavioral parent training in children with ADHD: a pilot study.
    van den Hoofdakker BJ; Nauta MH; Dijck-Brouwer DA; van der Veen-Mulders L; Sytema S; Emmelkamp PM; Minderaa RB; Hoekstra PJ
    Dev Psychol; 2012 Mar; 48(2):567-74. PubMed ID: 22182296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients.
    Gabriela ML; John DG; Magdalena BV; Ariadna GS; Francisco de LP; Liz SM; Lino PC; Josefina RG; Ernesto RZ; Carlos CF
    Neurosci Lett; 2009 Feb; 451(3):257-60. PubMed ID: 19146920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder.
    Bellgrove MA; Hawi Z; Kirley A; Fitzgerald M; Gill M; Robertson IH
    Neuropsychopharmacology; 2005 Dec; 30(12):2290-7. PubMed ID: 16123773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 40-bp VNTR polymorphism in the 3'-untranslated region of DAT1/SLC6A3 is associated with ADHD but not with alcoholism.
    Šerý O; Paclt I; Drtílková I; Theiner P; Kopečková M; Zvolský P; Balcar VJ
    Behav Brain Funct; 2015 Jun; 11():21. PubMed ID: 26058807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association studies of G352A polymorphism of dopamine transporter gene in Han Chinese attention deficit hyperactivity disorder patients].
    Qian QJ; Wang YF; Zhou RL; Yang L; Li J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 36(6):626-9. PubMed ID: 15605097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association study and a systematic meta-analysis of the VNTR polymorphism in the 3'-UTR of dopamine transporter gene and attention-deficit hyperactivity disorder.
    Grünblatt E; Werling AM; Roth A; Romanos M; Walitza S
    J Neural Transm (Vienna); 2019 Apr; 126(4):517-529. PubMed ID: 30923918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/hyperactivity disorder.
    Shaw P; Gornick M; Lerch J; Addington A; Seal J; Greenstein D; Sharp W; Evans A; Giedd JN; Castellanos FX; Rapoport JL
    Arch Gen Psychiatry; 2007 Aug; 64(8):921-31. PubMed ID: 17679637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine transporter (DAT1/SLC6A3) polymorphism and the association between being born small for gestational age and symptoms of ADHD.
    Waldie KE; Cornforth CM; Webb RE; Thompson JMD; Murphy R; Moreau D; Slykerman R; Morgan AR; Ferguson LR; Mitchell EA
    Behav Brain Res; 2017 Aug; 333():90-97. PubMed ID: 28666839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some ADHD polymorphisms (in genes DAT1, DRD2, DRD3, DBH, 5-HTT) in case-control study of 100 subjects 6-10 age.
    Kopecková M; Paclt I; Petrásek J; Pacltová D; Malíková M; Zagatová V
    Neuro Endocrinol Lett; 2008 Apr; 29(2):246-51. PubMed ID: 18404133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attention-deficit/hyperactivity disorder (ADHD) association with the DAT1 core promoter -67 T allele.
    Ohadi M; Shirazi E; Tehranidoosti M; Moghimi N; Keikhaee MR; Ehssani S; Aghajani A; Najmabadi H
    Brain Res; 2006 Jul; 1101(1):1-4. PubMed ID: 16782077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interacting effects of the dopamine transporter gene and psychosocial adversity on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-risk community sample.
    Laucht M; Skowronek MH; Becker K; Schmidt MH; Esser G; Schulze TG; Rietschel M
    Arch Gen Psychiatry; 2007 May; 64(5):585-90. PubMed ID: 17485610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination of DRD4 and DAT1 genotypes is an important risk factor for attention deficit disorder with hyperactivity families living in Santiago, Chile].
    Henríquez B H; Henríquez H M; Carrasco Ch X; Rothhammer A P; Llop R E; Aboitiz F; Rothhammer E F
    Rev Med Chil; 2008 Jun; 136(6):719-24. PubMed ID: 18769827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting the attention deficit hyperactivity disorder (ADHD) phenotype: sustained attention, response variability and spatial attentional asymmetries in relation to dopamine transporter (DAT1) genotype.
    Bellgrove MA; Hawi Z; Kirley A; Gill M; Robertson IH
    Neuropsychologia; 2005; 43(13):1847-57. PubMed ID: 16168728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk of attention deficit/hyperactivity disorder in Aymara and Rapa-Nui school children: association with dopaminergic system polymorphisms].
    Paz Lagos L; Silva C; Rothhammer P; Carrasco X; Llop E; Aboitiz F; Rothhammer F
    Rev Med Chil; 2011 May; 139(5):600-5. PubMed ID: 22051710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of preparation and response control in ADHD: the role of DRD4 and DAT1.
    Albrecht B; Brandeis D; Uebel-von Sandersleben H; Valko L; Heinrich H; Xu X; Drechsler R; Heise A; Kuntsi J; Müller UC; Asherson P; Steinhausen HC; Rothenberger A; Banaschewski T
    J Child Psychol Psychiatry; 2014 Aug; 55(8):914-23. PubMed ID: 24521003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine transporter genotype conveys familial risk of attention-deficit/hyperactivity disorder through striatal activation.
    Durston S; Fossella JA; Mulder MJ; Casey BJ; Ziermans TB; Vessaz MN; VAN Engeland H
    J Am Acad Child Adolesc Psychiatry; 2008 Jan; 47(1):61-67. PubMed ID: 18174826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between the dopamine transporter gene and the inattentive subtype of attention deficit hyperactivity disorder in Taiwan.
    Shang CY; Gau SS; Liu CM; Hwu HG
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):421-8. PubMed ID: 20800641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.